Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?

Methods for preventing medication-related osteonecrosis of the jaw (MRONJ) in cancer patients who have received high-dose bisphosphonate (BP) or denosumab (Dmab) have not yet been established. Tooth extraction after starting medication has been believed to be a major risk factor for MRONJ, and there...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS One
Главные авторы: Soutome, Sakiko, Hayashida, Saki, Funahara, Madoka, Sakamoto, Yuki, Kojima, Yuka, Yanamoto, Souichi, Umeda, Masahiro
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6062135/
https://ncbi.nlm.nih.gov/pubmed/30048523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0201343
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы